Clostridium difficile epidemiology has changed in recent years, with the emergence of highly
virulent types associated with severe infections, high rates of recurrences and mortality …

Clostridioides difficile infection (CDI) is one of the major issues in nosocomial infections.
This bacterium is constantly evolving and poses complex challenges for clinicians, often …

Clostridium (reclassified as “Clostridioides”) difficile infection (CDI) is a healthcare-
associated infection and significant source of potentially preventable morbidity, recurrence …

The rapid evolution of antibiotic resistance in Clostridium difficile and the consequent effects
on prevention and treatment of C. difficile infections (CDIs) are matter of concern for public …

Clostridium difficile ribotype (RT) 017 is an important toxigenic C. difficile RT which, due to a
deletion in the repetitive region of the tcdA gene, only produces functional toxin B. Strains …

Toxigenic culture and cytotoxicity assays are standard tests for detecting C. difficile infection
(CDI). Others include immunochromatographic strips, a rapid diagnostic test that detects …

Clostridioides (Clostridium) difficile is the leading cause of healthcare-associated infectious
diarrhea in the developed world. Retrospective studies have shown a lower incidence of C …

Clostridioides difficile causes healthcare-related diarrhoea in high-income countries. Highly
resistant spores persist in healthcare facilities, primarily infecting patients who have recently …

Clostridium difficile is a well-established hospital pathogen. Recently, it has been detected
increasingly in patients without hospital contact. Given this rise in community associated …

To increase understanding of the epidemiology, risks, consequences and resource
utilization of Clostridium difficile infection (CDI) in Japan, a systematic literature review was …